Sentences with phrase «tumor analysis»

The work is part of the National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium efforts.

He has also been leading statistical data analysis for the Broad Institute's Proteome Characterization Center and Proteogenomic Data Analysis Center established under the National Cancer Institute Clinical Proteomics Tumor Analysis Consortium (CPTAC), focusing on proteogenomic analysis of proteomic, phosphoproteomic, and genomic data derived from cancer samples.

«New tumor analysis method identifies high - risk prostate cancer: Cancer cells» genetic pathways show which patients are likely to develop aggressive types of the disease.»

This panel is based on initial standards defined by the Actionable Genome Consortium, and is expected to drive the adoption NGS for tumor analysis in translational research.

A pair of biostatisticians» questions about a prominent genetics group at Duke University have not only raised doubts about a popular method of tumor analysis but also led to accusations that a cancer researcher had padded his resumé.

Previously, genetic counselors tested a small number of genes sequentially based on family profile and tumor analysis until the culprit was identified.

«This strategy of «keeping up with the tumor» may be better than matching drugs based solely on the primary tumor analysis and then, when this fails, proceeding blindly to the next therapy, as is the current approach.»

Unlike most other genomic testing programs, Profile tumor analysis is offered to all patients regardless of age, cancer type, or stage of the cancer.

She explores solid tumor analysis by NGS, explaining that annotation is directed at FDA - approved drugs in selected tumor types.

Tumor analyses commonly employ a correction with a matched normal (MN), a sample from healthy tissue of the same individual, in order to distinguish germline mutations from somatic mutations.

The National Cancer Institute, part of the National Institutes of Health, picked the lab as part of the launch of the Clinical Proteomic Tumor Analysis Consortium, or CPTAC.

The center is part of the NCI's Clinical Proteomic Tumor Analysis Consortium.

Using only the tumor analysis, the tests spotted an average of 382 mutations per case that appeared associated with cancer.